Literature DB >> 11238292

Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.

H K Meier-Ewert1, P M Ridker, N Rifai, N Price, D F Dinges, J M Mullington.   

Abstract

BACKGROUND: The concentration of C-reactive protein (CRP) in otherwise healthy subjects has been shown to predict future risk of myocardial infarction and stroke. CRP is synthesized by the liver in response to interleukin-6, the serum concentration of which is subject to diurnal variation.
METHODS: To examine the existence of a time-of-day effect for baseline CRP values, we determined CRP concentrations in hourly blood samples drawn from healthy subjects (10 males, 3 females; age range, 21-35 years) during a baseline day in a controlled environment (8 h of nighttime sleep).
RESULTS: Overall CRP concentrations were low, with only three subjects having CRP concentrations >2 mg/L. Comparison of raw data showed stability of CRP concentrations throughout the 24 h studied. When compared with cutoff values of CRP quintile derived from population-based studies, misclassification of greater than one quintile did not occur as a result of diurnal variation in any of the subjects studied. Nonparametric ANOVA comparing different time points showed no significant differences for both raw and z-transformed data. Analysis for rhythmic diurnal variation using a method fitting a cosine curve to the group data was negative.
CONCLUSIONS: Our data show that baseline CRP concentrations are not subject to time-of-day variation and thus help to explain why CRP concentrations are a better predictor of vascular risk than interleukin-6. Determination of CRP for cardiovascular risk prediction may be performed without concern for diurnal variation.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Substances:

Year:  2001        PMID: 11238292

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  100 in total

1.  Salivary C-reactive protein among at-risk adolescents: A methods investigation of out of range immunoassay data.

Authors:  E R Landau; J Trinder; J G Simmons; M Raniti; M Blake; J M Waloszek; L Blake; O Schwartz; G Murray; N B Allen; M L Byrne
Journal:  Psychoneuroendocrinology       Date:  2018-09-08       Impact factor: 4.905

2.  Let her sleep...but how much?

Authors:  Janet M Mullington
Journal:  Sleep       Date:  2009-07       Impact factor: 5.849

Review 3.  Serum inflammatory markers in obstructive sleep apnea: a meta-analysis.

Authors:  Rashid Nadeem; Janos Molnar; Essam M Madbouly; Mahwish Nida; Saurabh Aggarwal; Hassan Sajid; Jawed Naseem; Rohit Loomba
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

4.  Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006.

Authors:  Kelly K Ferguson; Rita Loch-Caruso; John D Meeker
Journal:  Environ Res       Date:  2011-02-23       Impact factor: 6.498

5.  CRP gene (1059G>C) polymorphism and its plasma levels in ischemic stroke and hemorrhagic stroke in a south Indian population.

Authors:  Satrupa Das; Sitara Roy; Subhash Kaul; Akka Jyothy; Anjana Munshi
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 6.  Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.

Authors:  M Ariel Geer Wallace; Tzipporah M Kormos; Joachim D Pleil
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2016-10-19       Impact factor: 6.393

7.  A prospective follow-up study of the relationship between C-reactive protein and human cancer risk in the Chinese Kailuan Female Cohort.

Authors:  Gang Wang; Ni Li; Sheng Chang; Bryan A Bassig; Lanwei Guo; Jiansong Ren; Kai Su; Fang Li; Shuohua Chen; Shouling Wu; Yuhuan Zou; Min Dai; Tongzhang Zheng; Jie He
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-09       Impact factor: 4.254

8.  Fasting and postprandial markers of inflammation in lean and overweight children.

Authors:  Jessica A Alvarez; Paul B Higgins; Robert A Oster; José R Fernandez; Betty E Darnell; Barbara A Gower
Journal:  Am J Clin Nutr       Date:  2009-02-11       Impact factor: 7.045

Review 9.  Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Authors:  Sridevi Devaraj; Simona Valleggi; David Siegel; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

Review 10.  CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?

Authors:  Brendon J Coventry; Martin L Ashdown; Michael A Quinn; Svetomir N Markovic; Steven L Yatomi-Clarke; Andrew P Robinson
Journal:  J Transl Med       Date:  2009-11-30       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.